Search results
  1. Sep 5

    can cause many symptoms. RT to share the facts.

    25 retweets 19 likes
  2. Sep 10

    Post-hoc analysis of phase 3 in metastatic shows no difference in mOS among chemotherapy arms

    22 retweets 28 likes
  3. 15 hours ago

    Tour de force review of genomics, potential future paradigms by

    13 retweets 12 likes
  4. Sep 10

    . et al sequenced ~ 2000 UC samples. MSI high rare.

    1 reply 7 retweets 10 likes
  5. Sep 10

    High tumor mutational burden assessed w whole exome sequencing correlates with response to nivolumab in checkmate275

    2 replies 23 retweets 24 likes
  6. 15 hours ago

    Looking forward to welcoming overseas colleagues to Houston for

    1 reply 6 likes
  7. Sep 10

    Comparing atezo & pembro phase 3 trials, more liver mets and worse PS in KN45 vinflunine arm may have helped pembro.

    2 replies 15 retweets 21 likes
  8. Sep 9

    . asks the question: Should we be doing extended LND during Radical Cystectomy?

    1 retweet
  9. 9 hours ago

    Pick up a Watson's Blend natural soy candle and proceeds will be donated to Canada BCC

    1 retweet 1 like
  10. 11 hours ago

    A Conversation With 's Founder: Let's Talk About | Understanding Biomarkers

    2 likes
  11. 14 hours ago

    Lymph node dissection in includes removal of nodes along the external iliac blood vessels

    4 retweets 5 likes
  12. Sep 10

    RANGE phase 3: ramucirumab + docetaxel improved PFS and ORR vs placebo + docetaxel in metastatic . OS data not mature

    1 reply 6 retweets 11 likes
  13. Sep 10

    Treatment beyond progression with is safe & shows RECIST responses in metastatic

    9 retweets 15 likes
  14. Sep 10

    More evidence that mutational burden is the major player in response immune checkpoint inhibitors in

    High tumor mutational burden assessed w whole exome sequencing correlates with response to nivolumab in checkmate275
    4 retweets 6 likes
  15. Sep 10

    Treatment beyond progression with ICB in - is it progression or pseudoprogression??

    3 retweets 3 likes
  16. Sep 10

    Great to see these prognostic factors in developed @ in clinical use!

    6 retweets 12 likes
  17. Sep 10

    . gives a delightful overview of abstracts at ! Nice work!

    6 retweets 21 likes
  18. Sep 10

    Doctors are always looking for new treatments for their patients. Check out our new data at :

    6 retweets 10 likes
  19. Sep 10

    Today 14:40 Comparisson TMB in relevant molec subsets of mUC

    4 retweets 4 likes
  20. Sep 9

    The last session of the day is w/ moderators: Dr. Peter Wiklund and

    6 retweets 5 likes

No results.

Loading seems to be taking a while.

Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.